AI-Enhanced App for Nicotine Addiction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a smartphone app designed to help young people quit using e-cigarettes. The app provides tools to manage cravings, set personal goals, and interact with a chatbot for motivation. Researchers aim to determine if immediate use of the app is more effective than starting it three months later. Teens and young adults aged 14-20 who have used e-cigarettes in the past month and own a smartphone may be suitable participants. The study seeks to make quitting more accessible and effective for those ready to stop. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could simplify quitting e-cigarettes for many young people.
Do I have to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on using a smartphone app to help quit e-cigarettes.
What prior data suggests that this app is safe for adolescents?
Research has shown that using AI tools, like the app in this study, is generally safe. These tools have helped people quit smoking by tracking habits and providing personalized advice. A similar app with a chatbot that assisted users in quitting smoking showed good results without major safety issues.
AI-powered apps are designed to meet users' needs, offering real-time help such as answering questions and providing motivation. This makes them a low-risk choice for those trying to quit e-cigarettes. Other studies have shown that digital tools, like text message programs, have also helped teens quit without significant problems.
Overall, the app in this trial is expected to be safe for participants, using proven methods to help people quit e-cigarettes.12345Why are researchers excited about this trial?
Researchers are excited about the AI-Enhanced App for Nicotine Addiction because it offers a novel, tech-driven approach to helping adolescents quit e-cigarettes. Unlike traditional methods like nicotine replacement therapy or counseling, this treatment uses artificial intelligence to provide personalized support and feedback through a smartphone app. The app's immediate accessibility and tailored interventions make it a promising tool to engage young users who are tech-savvy. By comparing different timing strategies for using the app, researchers hope to uncover the optimal approach for maximizing quitting success.
What evidence suggests that this app is effective for quitting e-cigarettes?
Research shows that smartphone apps can help people quit smoking by offering real-time support and tracking progress. One study found that these apps led to more successful quitting. In this trial, participants will use an AI-enhanced app designed to help teenagers stop using e-cigarettes by managing cravings and boosting motivation to quit. Early evidence suggests that personalized, real-time support can improve quitting success. Participants in the immediate-intervention group will start using the app right after enrollment, while those in the delayed-intervention group will begin three months later, allowing for a comparison of the impact of timing on quitting success.16789
Are You a Good Fit for This Trial?
This trial is for adolescents aged 14-20 who are trying to quit e-cigarettes. Participants should be willing to use a smartphone app and engage with its features, like setting goals and tracking progress. There's no mention of specific exclusions in the provided information.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Development and Usability Testing
Participants test the app and provide feedback on usability and design to refine the app for deployment.
Clinical Feasibility Testing
Participants use the app to assess its impact on readiness to quit, quitting attempts, and motivation over time.
Follow-up
Participants are monitored for engagement and changes in e-cigarette use, including readiness to quit and quit attempts.
What Are the Treatments Tested in This Trial?
Interventions
- AI-Enhanced App-based Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
Advanced Bionics
Industry Sponsor
National Cancer Institute (NCI)
Collaborator